R&D Systems™ Recombinant Human VEGF 165 Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Product Code	Brand	Formulation	Quantity
18196930	R&D Systems™ 293-VE-050	Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein.	50μg
18167570	R&D Systems™ 293-VE-010/CF	Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA with trehalose.	10μg
18177350	R&D Systems™ 293-VE-010	Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein.	10μg
18117320	R&D Systems™ 293-VE-050/CF	Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA with trehalose.	50μg

Description

The Recombinant Human VEGF 165 Protein is derived from Sf 21 (baculovirus). The Recombinant Human VEGF 165 Protein has been validated for the following applications: Bioactivity.

Specifications

• Gene ID (Entrez): 7422
• Name: VEGF 165
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Recombinant: Recombinant

• Molecular Weight (g/mol): observed_molecular_weight: 20-22 kDa, under reducing conditions. 39-42 kDa, under non-reducing conditions.
• Source: Spodoptera frugiperda,Sf 21 (baculovirus)-derived human VEGF protein Ala27-Arg191
• Conjugate: Unconjugated
• Purity or Quality Grade: 97%, by SDS-PAGE with silver staining.